Hyundai Pharm (004310) — Working Capital to Net Assets Ratio
Hyundai Pharm (004310) has a Working Capital to Net Assets ratio of 16.1% as of February 2026. Working capital of ₩21.74 Billion (current assets of ₩100.63 Billion minus current liabilities of ₩78.90 Billion) is measured against net assets of ₩134.81 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how leveraged is Hyundai Pharm's balance sheet to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Hyundai Pharm Working Capital to Net Assets (2010–2025)
This chart shows how Hyundai Pharm's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2010 to 2025. As of February 2026, the ratio stands at 16.1%, reflecting working capital of ₩21.74 Billion against net assets of ₩134.81 Billion KRW. Check 004310 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Hyundai Pharm (2010–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Hyundai Pharm from 2010 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of Hyundai Pharm.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 11.5% | ₩9.42 Billion | ₩82.10 Billion | ₩80.83 Billion | ₩71.41 Billion | ▼ -14.9 pp |
| 2024 | 26.4% | ₩20.87 Billion | ₩79.07 Billion | ₩79.56 Billion | ₩58.69 Billion | ▲ +2.6 pp |
| 2023 | 23.8% | ₩20.14 Billion | ₩84.66 Billion | ₩85.47 Billion | ₩65.33 Billion | ▼ -0.4 pp |
| 2022 | 24.2% | ₩20.95 Billion | ₩86.56 Billion | ₩101.64 Billion | ₩80.70 Billion | ▼ -20.9 pp |
| 2021 | 45.1% | ₩39.05 Billion | ₩86.60 Billion | ₩84.90 Billion | ₩45.85 Billion | ▲ +13.2 pp |
| 2020 | 31.9% | ₩28.72 Billion | ₩90.14 Billion | ₩80.50 Billion | ₩51.78 Billion | ▲ +0.6 pp |
| 2019 | 31.3% | ₩27.40 Billion | ₩87.58 Billion | ₩71.64 Billion | ₩44.25 Billion | ▼ -11.5 pp |
| 2018 | 42.8% | ₩45.78 Billion | ₩107.00 Billion | ₩89.10 Billion | ₩43.32 Billion | ▲ +4.1 pp |
| 2017 | 38.6% | ₩37.91 Billion | ₩98.10 Billion | ₩86.93 Billion | ₩49.02 Billion | ▲ +0.8 pp |
| 2016 | 37.9% | ₩37.90 Billion | ₩100.08 Billion | ₩82.42 Billion | ₩44.52 Billion | ▼ -5.4 pp |
| 2013 | 43.3% | ₩43.83 Billion | ₩101.21 Billion | ₩80.48 Billion | ₩36.64 Billion | ▲ +0.8 pp |
| 2012 | 42.5% | ₩42.35 Billion | ₩99.69 Billion | ₩86.17 Billion | ₩43.82 Billion | ▲ +1.8 pp |
| 2011 | 40.7% | ₩42.45 Billion | ₩104.32 Billion | ₩87.51 Billion | ₩45.06 Billion | ▼ -5.6 pp |
| 2010 | 46.3% | ₩42.84 Billion | ₩92.50 Billion | ₩78.31 Billion | ₩35.47 Billion | — |